This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Mary Louise Michaelis
Introduction
Mary Louise Michaelis is a notable inventor based in Lawrence, KS (US). She has made significant contributions to the field of neuroprotective agents, showcasing her expertise and dedication to scientific advancement.
Latest Patents
Mary Louise Michaelis holds a patent for novel stereoisomers of GS-164. Her patent includes compounds such as (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol (TH-237A) and (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol (TH-242A). These compounds exhibit neuroprotective effects through a mechanism that does not involve microtubule stabilization.
Career Highlights
Mary Louise Michaelis is affiliated with the University of Kansas, where she continues her research and innovation in neuroprotective agents. Her work has garnered attention for its potential impact on neurological health and treatment options.
Collaborations
Some of her notable coworkers include Ingrid Gunda Georg and Richard H Himes. Their collaborative efforts contribute to the advancement of research in their respective fields.
Conclusion
Mary Louise Michaelis is a pioneering inventor whose work in neuroprotective agents has the potential to influence future medical treatments. Her contributions to science and collaboration with esteemed colleagues highlight her commitment to innovation and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile